Literature DB >> 24983212

Neuromodulation by acetylcholine: examples from schizophrenia and depression.

Michael J Higley1, Marina R Picciotto2.   

Abstract

The contribution of acetylcholine to psychiatric illnesses remains an area of active research. For example, increased understanding of mechanisms underlying cholinergic modulation of cortical function has provided insight into attentional dysfunction in schizophrenia. Acetylcholine normally enhances cortical sensitivity to external stimuli and decreases corticocortical communication, increasing focused attention; however, increases in ACh signaling can lead to symptoms related to anxiety and depression. For example, while stress-induced ACh release can result in adaptive responses to environmental stimuli, chronic elevations in cholinergic signaling may produce maladaptive behaviors. Here, we review several innovations in human imaging, molecular genetics and physiological control of circuits that have begun to identify mechanisms linking altered cholinergic neuromodulation to schizophrenia and depression.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24983212      PMCID: PMC4268065          DOI: 10.1016/j.conb.2014.06.004

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  89 in total

1.  Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention.

Authors:  Karine Guillem; Bernard Bloem; Rogier B Poorthuis; Maarten Loos; August B Smit; Uwe Maskos; Sabine Spijker; Huibert D Mansvelder
Journal:  Science       Date:  2011-08-12       Impact factor: 47.728

2.  Chronic exposure to typical or atypical antipsychotics in rodents: temporal effects on central alpha7 nicotinic acetylcholine receptors.

Authors:  A V Terry; D A Gearhart; S P Mahadik; S Warsi; L W Davis; J L Waller
Journal:  Neuroscience       Date:  2005-10-10       Impact factor: 3.590

Review 3.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

4.  Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats.

Authors:  J Turchi; M Sarter
Journal:  Brain Res Cogn Brain Res       Date:  1997-10

5.  Transdermal scopolamine psychosis.

Authors:  R K Osterholm; J K Camoriano
Journal:  JAMA       Date:  1982-06-11       Impact factor: 56.272

6.  Distinct muscarinic receptor subtypes suppress excitatory and inhibitory synaptic responses in cortical neurons.

Authors:  F Kimura; R W Baughman
Journal:  J Neurophysiol       Date:  1997-02       Impact factor: 2.714

7.  Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex.

Authors:  Evelyn K Lambe; Marina R Picciotto; George K Aghajanian
Journal:  Neuropsychopharmacology       Date:  2003-02       Impact factor: 7.853

8.  Prefrontal acetylcholine release controls cue detection on multiple timescales.

Authors:  Vinay Parikh; Rouba Kozak; Vicente Martinez; Martin Sarter
Journal:  Neuron       Date:  2007-10-04       Impact factor: 17.173

9.  Two types of muscarinic response to acetylcholine in mammalian cortical neurons.

Authors:  D A McCormick; D A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  48 in total

1.  Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate.

Authors:  Xuyi Yue; Hongjun Jin; Hui Liu; Zonghua Luo; Xiang Zhang; Kota Kaneshige; Hubert P Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu
Journal:  Org Biomol Chem       Date:  2017-06-21       Impact factor: 3.876

Review 2.  Neural control of brain state.

Authors:  Edward Zagha; David A McCormick
Journal:  Curr Opin Neurobiol       Date:  2014-10-10       Impact factor: 6.627

3.  Diverse Spatiotemporal Scales of Cholinergic Signaling in the Neocortex.

Authors:  Anita A Disney; Michael J Higley
Journal:  J Neurosci       Date:  2020-01-22       Impact factor: 6.167

4.  Cholinergic Modulation of CA1 Pyramidal Cells via M1 Muscarinic Receptor Activation: A Computational Study at Physiological and Supraphysiological Levels.

Authors:  Adam R Mergenthal; Jean-Marie C Bouteiller; Theodore W Berger
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2018-07

5.  Cortical cholinergic signaling controls the detection of cues.

Authors:  Howard J Gritton; William M Howe; Caitlin S Mallory; Vaughn L Hetrick; Joshua D Berke; Martin Sarter
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

6.  Synthesis and structure-activity relationships of a series of 4-methoxy-3-(piperidin-4-yl)oxy benzamides as novel inhibitors of the presynaptic choline transporter.

Authors:  Sean R Bollinger; Darren W Engers; Elizabeth A Ennis; Jane Wright; Charles W Locuson; Craig W Lindsley; Randy D Blakely; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2015-02-28       Impact factor: 2.823

Review 7.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

Review 8.  Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.

Authors:  Elizabeth C Ballinger; Mala Ananth; David A Talmage; Lorna W Role
Journal:  Neuron       Date:  2016-09-21       Impact factor: 17.173

9.  Nanoscopic Visualization of Restricted Nonvolume Cholinergic and Monoaminergic Transmission with Genetically Encoded Sensors.

Authors:  Paula K Zhu; W Sharon Zheng; Peng Zhang; Miao Jing; Philip M Borden; Farhan Ali; Kaiming Guo; Jiesi Feng; Jonathan S Marvin; Yali Wang; Jinxia Wan; Li Gan; Alex C Kwan; Li Lin; Loren L Looger; Yulong Li; Yajun Zhang
Journal:  Nano Lett       Date:  2020-05-12       Impact factor: 11.189

10.  Converging evidence that short-active photoperiod increases acetylcholine signaling in the hippocampus.

Authors:  Zackary A Cope; Maria L Lavadia; Aniek J M Joosen; Chuck J A van de Cappelle; Joseph C Lara; Alexandra Huval; Molly K Kwiatkowski; Marina R Picciotto; Yann S Mineur; Davide Dulcis; Jared W Young
Journal:  Cogn Affect Behav Neurosci       Date:  2020-12       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.